Author

P. Romecin

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Assay:CITE-seq· 1 Research Focus:differential expression· 1 Assay:flow cytometry· 1

Frequent Co-Authors

F. Gutierrez-Aguera· 2 shared P. Menendez· 2 shared A. Bataller· 1 shared A. Closa· 1 shared A. Martinez-Moreno· 1 shared B. Silva-Santos· 1 shared C. Bueno· 1 shared D. Sanchez Martinez· 1 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

F. Gutierrez-Aguera

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Generation and proof-of-concept for allogeneic CD123 CAR-Delta One T (DOT) cells in Acute Myeloid Leukemia

D. Sanchez Martinez, N. Tirado, S. Mensurado, A. Martinez-Moreno, P. Romecin, F. Gutierrez-Aguera, D. V. Correia, B. Silva-Santos, P. Menendez

This study generates and pre-clinically validates CD123-targeted CAR-DOTs for relapsed/refractory AML, showing robust cytotoxicity and long-term persistence with IL-15 support.

bioRxiv · Mar 15, 2022Immunology

A comprehensive single-cell expression atlas of human AML leukemia-initiating cells unravels the contribution of HIF pathway and its therapeutic potential

T. Velasco-Hernandez, J. L. Trincado, M. Vinyoles, A. Closa, F. Gutierrez-Aguera, O. Molina, V. C. Rodriguez-Cortez, P. Petazzi, S. Beneyto-Calabuig, L. Velten, P. Romecin, R. Casquero, F. Abollo-Jimenez, R. Diaz de la Guardia, P. Lorden, , P. Menendez

The paper creates a single-cell atlas of AML leukemia-initiating cells and shows that targeting the HIF pathway enhances chemotherapy effectiveness against these cells.

bioRxiv · Mar 2, 2022 · PreprintCancer Biology